Form 4: Acadia Pharmaceuticals Director Sells Shares
SEC Form 4
Elizabeth A. Garofalo, a director at Acadia Pharmaceuticals, sold 4,919 shares of common stock at a price of $18.23 on March 5, 2025.
Summary
- On March 5, 2025, Elizabeth A. Garofalo, a director of Acadia Pharmaceuticals, sold 4,919 shares of the company's common stock.
- The sale price was $18.23 per share.
- Following the transaction, Garofalo directly owns 17,595 shares of Acadia Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by a director. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of a transaction by a company insider. It provides transparency into the trading activities of individuals with access to non-public information.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although it is a relatively small transaction.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction: Sale of common stock. |
| 03/06/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.